Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 1151-1154

  Kokado, Y ^a   Takahara, S ^a   Kyo, M ^a   Ichimaru, N ^a   Toki, K ^a   Wang, J D ^a   Okuyama, A ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; GRAFT SURVIVAL; HLA SYSTEM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERKALEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MORTALITY; NEPHROTOXICITY; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTOPENIA;

ANTILYMPHOCYTE SERUM; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; METHYLPREDNISOLONE; MUROMONAB-CD3; PREDNISOLONE; RETROSPECTIVE STUDIES; RIBONUCLEOSIDES; TACROLIMUS; TIME FACTORS;

EID: 0033019706     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01942-3     Document Type: Conference Paper

References (7)

1. Jensen C.W.B., Jordan M.L., Schneck F.X., et al. Transplant Proc. 23:1991;3075.
2. Transplant Proc. 23:1991;3111.
3. Starzl T.E., Fung J.J., Jordan M., et al. JAMA. 264:1990;63.
4. Pirsch J.D., Miller J., Deierhoi M.H., et al. Transplantation. 63:1997;977.
5. Transplant Proc. 27:1995;818.
6. Transplant Proc. 27:1995;829.
7. Giertson D.W., Cecka J.M., Terasaki P.L. Transplantation. 60:1995;1384.